Please join us in celebrating ACPMP Medical Advisory Board member Dr. John Paul Shen, a physician-scientist at MD Anderson Cancer Center, for being recognized by Conquer Cancer, the ASCO Foundation, for his work to improve outcomes for patients with appendix cancer! His research focuses on developing chemotherapy options designed specifically for appendix cancer, repurposing existing drugs, and addressing the unique...

Article originally posted on July 30, 3025, on curetoday.com Author(s):Patti McGee: author, a massage therapist and breast cancer survivor of 20 years Fact checked by:Ryan Scott Listen to Audio Version Key Takeaways Building a strong support system is essential for navigating a cancer diagnosis, providing emotional and practical assistance. Assembling a trusted medical team and participating in support groups can...

In a significant move to raise awareness about a rare and challenging cancer that is on the rise, prominent buildings across the country will turn amber throughout August, recognized as Appendix Cancer Awareness Month. This initiative aims to shed light on appendix cancer, its increasing incidence, and the critical need for early detection and research. Appendix Cancer on the Rise...

We are proud to share new research led by our Scientific Advisory Board Chair, Dr. Andreana Holowatyj, and published in the Annals of Internal Medicine, finding that appendix cancer rates have quadrupled among Millennials. This landmark study, funded in part by The Appendix Cancer Research Foundation and the National Institutes of Health, was featured in The New York Times, TIME...

Patient Power recently invited cancer patients to share their individual thoughts, feelings, and experiences from diagnosis and beyond. The responses were then reported in the article below. They are all insightful and highlight the many challenges. Notably, the patient community as a whole reported many of the same perceptions and experiences. The responses are provided below. As we often say,...

Explore Our Refreshed and Expanded Clinical Trials Database ACPMP is excited to announce a significant update to our Clinical Trials Database – an important resource for physicians and their patients seeking clinical trials for appendix cancer. This update is part of our larger effort to provide the appendix cancer community with the most current and comprehensive information available. Here are...

The Appendix Cancer PMP Research Foundation (ACPMP) proudly announces the publication of a landmark article in Nature Reviews Cancer entitled “Defining a 'cells to society' research framework for appendiceal tumors.” This pivotal Expert Recommendation, officially published online on February 20, is the direct result of the Appendix Cancer PMP Research Foundation Scientific Think Tank—an innovative, multidisciplinary gathering designed to advance...

Thanks to the generosity of our donors, ACPMP is proud to fund two 2025 Society of Surgical Oncology (SSO) research grants focused solely on appendix cancer and PMP—including a significant new award in memory of our founder. SSO advances cancer research by providing research funding through its competitive Clinical Investigator and Young Investigator Awards programs. Introducing the Lisa Kurtz Luciano Appendix Cancer and Pseudomyxoma...

February is recognized as National Cancer Prevention Month, an important time to discuss ways to reduce cancer risks and promote overall health. Yet, for appendix cancer—including Pseudomyxoma Peritonei (PMP)—no specific causes have been definitively identified. Below, we’ll explore what is currently known about appendix cancer, share general cancer prevention strategies recommended by leading authorities, and highlight the importance of ongoing...

$50,000 Grant Awarded to Dr. Andrew Lowy for Groundbreaking Research on Mucinous Appendix Cancer SPRINGFIELD, PA, UNITED STATES, December 19, 2024 /EINPresswire.com/ -- The Appendix Cancer PMP Research Foundation (ACPMP) is pleased to announce a historic achievement: the launch of a second Catalyst Research Grant cycle within the same year, culminating in the funding of a third $50,000 research grant in 2024....